2022
DOI: 10.1016/j.cvsm.2022.02.005
|View full text |Cite
|
Sign up to set email alerts
|

Platelet-Rich Plasma as an Orthobiologic

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
22
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(22 citation statements)
references
References 109 publications
0
22
0
Order By: Relevance
“…Multiple preparations of PRP have been developed and studied in humans, canines, felines, and equines; however, the constitutional makeup of the PRP varies greatly depending on the manufacturer, species, and method of processing, making equipment/processing specific validation important (19,20,22,34). Additionally, the constituent concentrations needed for a product to be considered PRP and have clinical efficacy are debated, with suggestions of platelet concentrations ranging from 1.5 to 5x those seen in whole blood (35)(36)(37)(38)(39)(40).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Multiple preparations of PRP have been developed and studied in humans, canines, felines, and equines; however, the constitutional makeup of the PRP varies greatly depending on the manufacturer, species, and method of processing, making equipment/processing specific validation important (19,20,22,34). Additionally, the constituent concentrations needed for a product to be considered PRP and have clinical efficacy are debated, with suggestions of platelet concentrations ranging from 1.5 to 5x those seen in whole blood (35)(36)(37)(38)(39)(40).…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, the constituent concentrations needed for a product to be considered PRP and have clinical efficacy are debated, with suggestions of platelet concentrations ranging from 1.5 to 5x those seen in whole blood (35)(36)(37)(38)(39)(40). While there is debate on whether various other constituents should be included or removed, recent studies have found that red blood cells (RBCs), neutrophils, and mononuclear cells may also affect the efficacy of a PRP product and how it contributes to the inflammatory response following PRP administration (19,41). RBCs and neutrophils are believed to be detrimental to the efficacy of intraarticular PRP as they induce unwanted inflammatory mediators that can cause synoviocyte death and impede intra-articular healing (41,42).…”
Section: Discussionmentioning
confidence: 99%
“…In our study, better histological scores were obtained in rabbits treated with IA combined with IO injections of PRGF. The use of PRP to treat musculoskeletal disorders, including OA and chondral defects, has gained interest in veterinary clinical practice during the last years and IA infiltration has shown positive clinical and functional outcomes ( 43 47 ). However, in patients severely affected, the IA therapy is not able to reach all the structures involved in OA pathology, especially the SB ( 48 ).…”
Section: Discussionmentioning
confidence: 99%
“…Activation of platelets in the PC, before their use, creates a scaffold-like membrane named platelet gel and an acellular platelet lysate (127) . There is limited consensus on variables for clinical applications, such as the total number of platelets, methods of activation, preparation, and presence or absence of white blood cells, among others, that make their use inconsistent and highly variable among research groups (128) . Therefore, standardized methods for platelet-derived products are still required.…”
Section: Cell Mediatorsmentioning
confidence: 99%
“…In veterinary medicine, treatments with platelet-derived products are typically used in musculoskeletal conditions, wound defects, and articular lesions, mainly in equine, canine, and feline patients (126) . Typically, all mentioned species, including humans, are treated with PRP or derived products for skin wounds, corneal ulcers, maxillofacial/oral surgeries, tendinopathies, articular injuries, and musculoskeletal problems (128) .…”
Section: Cell Mediatorsmentioning
confidence: 99%